Journal: eLife
Article Title: A novel mouse model for LAMA2 -related muscular dystrophy with analysis of molecular pathogenesis and clinical phenotype
doi: 10.7554/eLife.94288
Figure Lengend Snippet: ( A ) Quantitative analysis of immunofluorescence staining for myosin heavy chain (MYHC), MYOG, desmin, MYOD1, β-tubulin, and MYF-5 in wild-type (WT) and dy H /dy H muscles at P14. ( B ) Quantitative analysis of Western blot for laminin α2, F-actin, α-actin, MYH2, MYHC, desmin, β-tubulin, MYOG, and MYOD1 in P14 WT and dy H /dy H muscles. *** for p-value <0.001, ** for p-value <0.01, * for p-value <0.05.
Article Snippet: Immunofluorescence was performed according to standard procedures with antibodies against the N-terminus of the laminin α2 chain (rat monoclonal, 4H8-2, Sigma, Saint Louis, USA), the laminin α1 chain (rat monoclonal, MAB4656, R&D Systems, Minneapolis, USA), myogenic differentiation antigen 1 (MYOD1) (mouse monoclonal, ab16148, Abcam, Cambridge, UK), myogenin (MYOG) (mouse monoclonal, MAB66861, R&D Systems, Minneapolis, USA), myogenic factor 5 (MYF5) (mouse monoclonal, MAB4027, R&D Systems, Minneapolis, USA), myosin heavy chain (MYHC) (mouse monoclonal, MAB4470, R&D Systems, Minneapolis, USA), desmin (mouse monoclonal, MA5-15306, Invitrogen, CA), CD68 (rabbit IgG, BA3638, Boster, CA), and clone IIH6C4 for α-DG (mouse monoclonal, 05–593, Merck Millipore, Darmstadt, Germany).
Techniques: Immunofluorescence, Staining, Muscles, Western Blot